review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Nina J Solenski | |
Gary Fiskum | |||
Robert E Rosenthal | |||
Santina A Zanelli | |||
P2860 | cites work | Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2. | Q40473279 |
Inhibition of glutamate-induced delayed calcium deregulation by 2-APB and La3+ in cultured cortical neurones | Q42468259 | ||
The action of acetyl-L-carnitine on the neurotoxicity evoked by amyloid fragments and peroxide on primary rat cortical neurones | Q43681257 | ||
Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons | Q44105695 | ||
Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels | Q44116932 | ||
Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. | Q44163178 | ||
Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine | Q44561744 | ||
Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats | Q45031998 | ||
Delayed therapy of experimental global cerebral ischemia with acetyl-L-carnitine in dogs | Q46386935 | ||
Postischemic inhibition of cerebral cortex pyruvate dehydrogenase | Q48111412 | ||
Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat--study by 13P- and 1H-NMR spectroscopy | Q48138878 | ||
Neuroprotective activity of acetyl-L-carnitine: studies in vitro | Q48225534 | ||
Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine | Q48434034 | ||
The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. | Q48568773 | ||
Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. | Q51660588 | ||
Acetyl-L-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult | Q70921038 | ||
Fatty acid-induced Ca(2+)-dependent uncoupling and activation of external pathway of NADH oxidation are coupled to cyclosporin A-sensitive mitochondrial permeability transition | Q72131555 | ||
Inhibition of postcardiac arrest brain protein oxidation by acetyl-L-carnitine | Q72316119 | ||
Neuroprotective effects of acetyl-L-carnitine after stroke in rats | Q73396042 | ||
Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation | Q73466354 | ||
Anti-apoptotic effect of acetyl-l-carnitine and I-carnitine in primary cultured neurons | Q74119224 | ||
Mitochondrial mechanisms of neural cell apoptosis | Q35876358 | ||
Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress | Q35962098 | ||
Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock | Q36081404 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 153-161 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
P1476 | title | Mechanisms of ischemic neuroprotection by acetyl-L-carnitine | |
P478 | volume | 1053 |
Q91039108 | A linked organ-on-chip model of the human neurovascular unit reveals the metabolic coupling of endothelial and neuronal cells |
Q64093631 | A metabolomic approach to identifying biomarkers in blood of Alzheimer's disease |
Q33909566 | A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism |
Q48444656 | Acetyl-L-carnitine and oxaloacetate in post-treatment against LTP impairment in a rat ischemia model. An in vitro electrophysiological study. |
Q89709473 | Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes |
Q90073266 | Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7 |
Q28751860 | Alternative medicine and Alzheimer disease |
Q30575263 | Ammonia toxicity to the brain |
Q37396091 | Augmentation of normal and glutamate-impaired neuronal respiratory capacity by exogenous alternative biofuels |
Q37209852 | Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine |
Q34772905 | Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. |
Q37708713 | Current concepts in the pathogenesis of urea cycle disorders |
Q41419380 | Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome |
Q53255085 | Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortex. |
Q35313382 | Effects of silver nanoparticles on human and rat embryonic neural stem cells |
Q37783543 | Encephalopathies: the emerging diabetic complications |
Q43978332 | Guidelines for using mouse global cerebral ischemia models |
Q37856806 | Hyperammonemia in review: pathophysiology, diagnosis, and treatment |
Q92238370 | In vivo and in vitro knockout system labelled using fluorescent protein via microhomology-mediated end joining |
Q35674930 | In vivo longitudinal proton magnetic resonance spectroscopy on neonatal hypoxic-ischemic rat brain injury: Neuroprotective effects of acetyl-L-carnitine |
Q36554951 | Intrathecal Acetyl-L-Carnitine Protects Tissue and Improves Function after a Mild Contusive Spinal Cord Injury in Rats |
Q50583315 | L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. |
Q39101800 | Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments |
Q37105412 | Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain |
Q52621890 | Mitochondrial Agents for Bipolar Disorder. |
Q34988707 | Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury |
Q92502863 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review |
Q34777969 | Neuroprotection by acetyl-L-carnitine after traumatic injury to the immature rat brain |
Q51615949 | Neuroprotective Effects of Acetyl-L-Carnitine Against Oxygen-Glucose Deprivation-Induced Neural Stem Cell Death. |
Q47850833 | Neuroprotective Effects of Acetyl-L-Carnitine on Neonatal Hypoxia Ischemia-Induced Brain Injury in Rats |
Q34345646 | Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats |
Q42613803 | Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro |
Q27023108 | Novel mitochondrial targets for neuroprotection |
Q58698335 | Organic and Peptidyl Constituents of Snake Venoms: The Picture Is Vastly More Complex Than We Imagined |
Q36571464 | Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. |
Q48680781 | Protective effects of acetyl-L-carnitine on neurodegenarative changes in chronic cerebral ischemia models and learning-memory impairment in aged rats |
Q91955533 | Pyruvate dehydrogenase complex in cerebral ischemia-reperfusion injury |
Q36926979 | Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy |
Q46326696 | Sodium azide induced neuronal damage in vitro: evidence for non-apoptotic cell death |
Q36105578 | The effect of combined therapy of exercise and nootropic agent on cognitive function in focal cerebral infarction rat model |
Q36775895 | The mitochondrial permeability transition in neurologic disease |
Q39374279 | The neurochemistry of peripheral nerve regeneration. |
Q97520923 | Time Course of Metabolomic Alterations in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage |
Q47268040 | l-Acetylcarnitine: A Mechanistically Distinctive and Potentially Rapid-Acting Antidepressant Drug |
Search more.